Found: 20
Select item for more details and to access through your institution.
Anti-tumour necrosis factor-α therapies in Crohn's disease.
- Published in:
- British Journal of Hospital Medicine (17508460), 2009, v. 70, n. 11, p. 644, doi. 10.12968/hmed.2009.70.11.45055
- By:
- Publication type:
- Article
Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Assignment<FOOTREF>[sup 1] </FOOTREF> of GALGT encoding β-1,4N-acetylgalactosaminyl-transferase (GalNAc-T) and KIF5A encoding neuronal kinesin (D12S1889) to human chromosome band 12q13 by assignment to ICI YAC 26EG10 and in situ hybridization.
- Published in:
- Cytogenetics & Cell Genetics, 1998, v. 82, n. 3/4, p. 267, doi. 10.1159/000015115
- By:
- Publication type:
- Article
Infliximab and surgical treatment of complex anal Crohn's disease.
- Published in:
- Colorectal Disease, 2012, v. 14, n. 8, p. 972, doi. 10.1111/j.1463-1318.2011.02811.x
- By:
- Publication type:
- Article
Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts? Authors' reply.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 4, p. 389, doi. 10.1111/apt.14203
- By:
- Publication type:
- Article
The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 63, doi. 10.1111/apt.13831
- By:
- Publication type:
- Article
Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 8, p. 988, doi. 10.1111/apt.12436
- By:
- Publication type:
- Article
Commentary: infliximab or adalimumab in Crohn's disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 4, p. 398, doi. 10.1111/j.1365-2036.2012.05167.x
- By:
- Publication type:
- Article
Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 8, p. 957, doi. 10.1111/j.1365-2036.2012.05034.x
- By:
- Publication type:
- Article
Is propionyl- l-carnitine therapy effective in ulcerative colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 2, p. 315, doi. 10.1111/j.1365-2036.2011.04913.x
- By:
- Publication type:
- Article
Anti-TNF associated psoriasis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 2, p. 308, doi. 10.1111/j.1365-2036.2011.04928.x
- By:
- Publication type:
- Article
Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 2, p. 284, doi. 10.1111/j.1365-2036.2011.04925.x
- By:
- Publication type:
- Article
Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection: authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 4, p. 498, doi. 10.1111/j.1365-2036.2010.04553.x
- By:
- Publication type:
- Article
Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis: authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 2, p. 289, doi. 10.1111/j.1365-2036.2010.04524.x
- By:
- Publication type:
- Article
Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates Letters to the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1294, doi. 10.1111/j.1365-2036.2010.04478.x
- By:
- Publication type:
- Article
Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience M. B. Sprakes et al. Cost of care after infliximab for Crohn's.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 11/12, p. 1357, doi. 10.1111/j.1365-2036.2010.04482.x
- By:
- Publication type:
- Article
Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis S. Thanaraj et al. Systematic review: granulocyte/monocyte apheresis for UC.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 11/12, p. 1297, doi. 10.1111/j.1365-2036.2010.04490.x
- By:
- Publication type:
- Article
Effect of oral zinc in hepatic encephalopathy remains unclear Letters to the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 11/12, p. 1405, doi. 10.1111/j.1365-2036.2010.04483.x
- By:
- Publication type:
- Article
Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 12, p. 1456, doi. 10.1016/j.crohns.2014.09.007
- By:
- Publication type:
- Article